The use of real-world evidence can prevent pharma companies from performing studies based on flawed data.
Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Articles by Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
2
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
3
Eli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs
4
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
5